Avanos Medical, Inc. (AVNS) Tops Q2 EPS by 31c, Revenues Beat; Boosts FY18 EPS, Sales Growth Guidance

Go back to Avanos Medical, Inc. (AVNS) Tops Q2 EPS by 31c, Revenues Beat; Boosts FY18 EPS, Sales Growth Guidance
(NYSE: AVNS) Delayed: 24.98 --0 (-0%)
Previous Close $24.98    52 Week High
Open $24.99    52 Week Low
Day High $25.00    P/E N/A 
Day Low $24.98    EPS
Volume 504,141